국소진행성 직장암의 수술 전 동시화학방사선요법의 결과 = Results of Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer

국문 초록 (Abstract)

목 적: 국소적으로 진행된 직장암환자에서 수술 전 동시화학방사선요법을 시행한 환자들의 항문 괄약근 보존율과
병기 강하율 등을 분석하고자 후향적 임상 연구를 시행하였다. 대상 및 방법: 2002년 1월부터 2005년 12월까지 조직학적으로 확진된 직장암 환자 중, 병기가 T2 이상이거나 림프절 전이가 있는 환자를 대상으로 하였다. 한림대학교 성심병원 방사선종양학과에서 수술 전 동시화학방사선요법을 시행 받은 36명 중, 본원에서 수술을 시행한 26명을 대상으로 연구를 시행하였다. 환자들은 수술 전 병기결정을 위한 검사를 시행하였고 방사선치료는 CT를 촬영하여 치료계획을 세웠으며 매일 1.8 Gy로 주 5회, 총 방사선 조사량 45.0∼52.2 Gy까지 3차원 방사선치료 방법으로 시행하였으며, 방사선치료 첫째 주와 다섯째 주에 5-FU와 leucovorine을 동시 투여하였다. 수술은 동시화학방사선요법 종료 후 약 2∼4주경에 시행하였다. 결 과: 대상 환자의 연령 중앙값은 61.9세(34∼78)였으며, 남자가 21명, 여자가 5명이었고 추적 관찰 기간의 중앙값은 28개월(11∼44)이었다. 모든 환자에서 절제연 음성인 근치절제가 가능하였으나 병리적으로 완전 반응을 보인
경우는 없었다. 수술은 3예에서 복회음부 절제술을, 나머지 23예에서 하전방절제술이 시행되어 괄약근 보존율은
88.5% (23/26)였다. 수술 후 병기 강하는 12예로 병기 강하율은 46.2%였으며 19예에서 종양 크기가 감소되어 종양
크기 감소율은 73%였다. 국소 재발이 1명, 원격 전이가 3명에서 관찰되었으며 3년 무재발 생존율은 96.7%, 3년 무
전이 생존율은 87%, 그리고 3년 무진행 생존율은 83.1%였다. 치료와 관련된 급성 독성으로는 Grade 3 & 4 빈혈
각각 1예, Grade 3 백혈구 감소증 1예, Grade 3 장폐색 1예가 관찰되었다. 결 론: 직장암 환자들에서 수술 전 동시화학방사선요법은 근치적 수술을 시행한 경우 높은 괄약근보존율과 수술후 병기감소율을 보였으며 치료에 따른 독성도 대부분 경미하고 높은 순응도를 보여 효과적인 방법으로 판단되며 앞으로 많은 환자들을 대상으로 장기간에 걸친 추적 관찰을 요한다.

다국어 초록 (Multilingual Abstract)

P urpose: We performed a retrospective non- randomized clinical study of locally advanced rectal cancer, to
evaluate the anal sphincter preservation rates, down staging rates and survival rates of preoperative
chemoradiotherapy. Materials and Methods: From January 2002 to December 2005, patients with pathologically confirmed rectal cancer with clinical stage T2 or higher, or patients with lymph node metastasis were enrolled in this study. A preoperative staging work- up was conducted in 36 patients. All patients were treated with preoperative chemoradiotherapy, and curative resection was performed for 26 patients at Hallym University Sacred Heart Hospital. Radiotherapy treatment planning was conducted with the use of planning CT for all patients. A total dose of 45.0∼52.2 Gy conventionally fractionated three- dimensional radiotherapy was delivered to the whole pelvis. Chemotherapy was given at the first and fifth week of radiation therapy with continuous infusion i.v. 5- FU (Fluorouracil) and LV (Leucovorine). Surgical resection was performed 2 to 4 weeks after the completion of the chemoradiotherapy regimen. R esults: The complete resection rate with negative resection margin was 100% (26/26). However, a pathologically complete response was not seen after curative resection. Surgery was done by LAR (low anterior resection) in 23 patients and APR (abdomino- perineal resection) in 3 patients. The sphincter preservation rate was 88.5% (23/26), down staging of the tumor occurred in 12 patients (46.2%) and down- sizing of the tumor occurred in 19 patients (73%). Local recurrence after surgical resection developed in 1 patient, and distant metastasis developed in 3 patients. The local recurrence free survival rate, distant metastasis free survival rate, and progression free survival rate were 96.7%, 87% and 83.1%, respectively. Treatment related toxicity was minimal except for one grade 3, one grade 4 anemia, one grade 3 leukopenia, and one grade 3 ileus. Conclusion: Preoperative concurrent chmoradiotherapy for locally advanced rectal cancer seems to have some potential benefits: high sphincter preservation and down staging. Treatment related toxicity was minimal and a high compliance with treatment was seen in this study. Further long- term follow- up with a larger group of patients is required

목차 (Table of Contents)

• 서 론
• 대상 및 방법
• 결 과
• 고안 및 결론

참고문헌 (Reference)

1 "Value of rectal ultrasound in predicting staging and outcome in patients with rectal adenocarcinoma" 47 : 1323-1330, 2004

2 "The role of preoperative adjuvant therapy in the management of borderline operability rectal cancer" 353-358, clinradiol1982;33

3 "The effects of preoperative radiation therapy in resectable rectal cancer: in view of pathologic aspects" 15 : 49-56, 1997

4 "The effect of preoperative concurrent chemoradiation in locally advanced rectal cancer" 21 : 89-99, 2005

5 "The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: longterm follow-up of a population-based study" 92 : 896-902, 2001

6 "Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy" 72 : 15-24, 2004

7 "Results of preoperative chemoradiotherapy in low rectal cancer" 24 : 21-29, 2006

8 Moore HG, "Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection" 47 : 279-286, 2004

9 Medical Research Council Rectal Cancer Working Party, "Randomized trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum" 348 : 1610-1614, 1996

10 Gastrointestinal Tumor Study Group, "Prolongation of disease-free interval in surgically treated rectal carcinoma" 1464-1472,

11 Mohiuddin M, "Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers" 48 : 1075-1080, 2000

12 "Preoperative staging of rectal carcinoma" 86 : 17-28, 1999

13 Stockholm Rectal Cancer Study Group, "Preoperative short- term radiotherapy in operable rectal carcinoma" 49-55,

14 "Preoperative radiotherapy for resectable rectal cancer: a meta-analysis" 284 : 1008-1015, 2000

15 "Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications" 37 : 619-627, 1997

16 "Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum" 234 : 633-640, 2001

17 Mendenhall WM, "Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum" 25-222,

18 Cohen AM, "Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer" 2859-2866,

19 "Preoperative concurrent radio-chemotherapy for rectal cancer: report of early results" 2 : 125-134, 2003

20 "Preoperative chemoradiation therapy in the management of locally advanced rectal cancer" 21 : 19-26, 2005

21 "Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma" 25 : 1006-1011, 2001

22 "Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response" 46 : 883-888, 2000

23 Cohen AM, "Phase I/II trial of preoperative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer" 387-392,

24 Quan SH, "Patterns of pelvic recurrence following definitive resection of rectal cancer" 1354-1362,

25 Marks G, "New hope and promise for sphincter preservation in the management of cancer of the rectum" 388-398, seminoncol1991;18

26 Martini N, "Neoadjuvant chemotherapy and surgery of cancer of the esophagus" 170-176, seminsurgoncol1986;2

27 "Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial" 17 : 2396-2402, 1999

28 "IImproved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial" 336 : 980-987, 1997

29 "Final results of a randomized trial on the treatement of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil followed by radical surgery Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group" 1811-1818

30 Chao M, "Evaluation of the use of computed tomography versus conventional X-ray simulation in the treatment of rectal cancer" 49 : 122-126, 2005

31 "Efficacy of preoperative radiochemotherapy in patients with advanced low rectal cancer" 20 : 46-51, 2004

32 "Efficacy of a preoperative concurrent chemoradiotherapy for the locally advanced unresectable rectal cancer" 18 : 293-299, 2000

33 "Effect of peroperative radiotherapy for T2, T3 distal rectal cancer" 20 : 215-220, 2002

34 Valentini V, "Does down staging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients" 53 : 664-674, 2002

35 "Clinical results of preoperative chemoradiation on advanced rectal cancers; tumor responses, toxicities, and mortality" 20 : 138-144, 2004

36 "Chemotherapy with preoperative radiotherapy in recal cancer" 335 : 1114-1123, 2006

37 "Cancer of breast Principle & Practice of Oncology" Lippincot Co 1264-1332, 1993

38 "Can magnetic resonance imaging predict circumferential margins and TMN stage in rectal cancer?" 47 : 1317-1322, 2004

39 "Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials" 358 : 1291-1304, 2001